Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In The News: Tracking The Latest Industry Personnel Moves

Executive Summary

Don Berwick steps down as CMS chief; new leadership at BIO Ventures for Global Health; former Pfizer CEO Kindler joins two boards of directors; more personnel announcements in this month’s column.

You may also be interested in...



CMS Administrator-Nominee Tavenner Would Bring Leadership Continuity As ACA Implementation Continues

With the selection of Centers for Medicare and Medicaid Services Principal Deputy Administrator Marilyn Tavenner as Don Berwick’s successor, the Obama administration appears to be seeking leadership continuity with a candidate that has a good chance of gaining Senate confirmation.

FDA Chief Of Staff Barclay Hails From Agency, By Way Of M Street

Lisa Barclay returns to government from Zuckerman Spaeder where she co-authored a report urging more regulation of nutritional supplements based on nanotechnology.

Former Pfizer CEO Kindler Named To Presidential Board On Government "Best Practices"

Jeffrey Kindler will bring the big pharma perspective to the newly-constituted President's Management Advisory Board.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054007

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel